VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,414,232 | -0.4% | 1,947,739 | +52.0% | 0.01% | 0.0% |
Q2 2023 | $8,444,940 | -8.8% | 1,281,478 | -6.0% | 0.01% | -10.0% |
Q1 2023 | $9,255,429 | +14.2% | 1,363,097 | +24.3% | 0.01% | +11.1% |
Q4 2022 | $8,102,654 | -9.2% | 1,096,435 | +21.4% | 0.01% | -18.2% |
Q3 2022 | $8,926,000 | -3.9% | 903,429 | +6.0% | 0.01% | 0.0% |
Q2 2022 | $9,286,000 | +22.7% | 851,978 | +27.3% | 0.01% | +57.1% |
Q1 2022 | $7,569,000 | -22.9% | 669,147 | +6.9% | 0.01% | -12.5% |
Q4 2021 | $9,823,000 | -30.6% | 626,060 | -24.2% | 0.01% | -38.5% |
Q3 2021 | $14,156,000 | -25.3% | 825,900 | -6.3% | 0.01% | -18.8% |
Q2 2021 | $18,958,000 | +67.3% | 881,347 | +16.8% | 0.02% | +45.5% |
Q1 2021 | $11,332,000 | +109.1% | 754,429 | +82.9% | 0.01% | +120.0% |
Q4 2020 | $5,419,000 | +3.4% | 412,459 | -24.0% | 0.01% | 0.0% |
Q3 2020 | $5,241,000 | -36.9% | 542,541 | -25.3% | 0.01% | -50.0% |
Q2 2020 | $8,304,000 | +31.2% | 725,904 | +18.8% | 0.01% | 0.0% |
Q1 2020 | $6,330,000 | +257.6% | 611,012 | +466.3% | 0.01% | +400.0% |
Q4 2019 | $1,770,000 | -53.9% | 107,893 | -62.7% | 0.00% | -60.0% |
Q3 2019 | $3,838,000 | +1223.4% | 288,963 | +1306.1% | 0.01% | – |
Q2 2019 | $290,000 | -48.9% | 20,550 | -33.4% | 0.00% | -100.0% |
Q1 2019 | $568,000 | -79.2% | 30,845 | -74.1% | 0.00% | -66.7% |
Q3 2018 | $2,728,000 | -58.0% | 118,872 | -65.1% | 0.00% | -62.5% |
Q2 2018 | $6,494,000 | +136.1% | 340,896 | +108.8% | 0.01% | +100.0% |
Q1 2018 | $2,751,000 | +8.8% | 163,275 | -1.9% | 0.00% | +33.3% |
Q4 2017 | $2,529,000 | -31.5% | 166,392 | -19.3% | 0.00% | -50.0% |
Q3 2017 | $3,693,000 | +7.5% | 206,293 | -2.1% | 0.01% | 0.0% |
Q2 2017 | $3,434,000 | -20.4% | 210,649 | -31.6% | 0.01% | -25.0% |
Q1 2017 | $4,313,000 | -19.0% | 308,112 | -7.6% | 0.01% | -11.1% |
Q4 2016 | $5,322,000 | -7.6% | 333,619 | -3.6% | 0.01% | -10.0% |
Q3 2016 | $5,758,000 | +134.2% | 346,055 | +57.5% | 0.01% | +100.0% |
Q2 2016 | $2,459,000 | +561.0% | 219,757 | +393.7% | 0.01% | +400.0% |
Q1 2016 | $372,000 | +144.7% | 44,512 | +173.1% | 0.00% | – |
Q4 2015 | $152,000 | -77.8% | 16,297 | -73.2% | 0.00% | -100.0% |
Q3 2015 | $685,000 | -76.7% | 60,700 | -73.8% | 0.00% | -75.0% |
Q2 2015 | $2,945,000 | -10.2% | 232,062 | -34.2% | 0.00% | -20.0% |
Q1 2015 | $3,281,000 | -38.0% | 352,781 | -4.5% | 0.01% | -28.6% |
Q4 2014 | $5,288,000 | +1126.9% | 369,271 | +790.1% | 0.01% | +600.0% |
Q3 2014 | $431,000 | -83.4% | 41,488 | -74.1% | 0.00% | -75.0% |
Q2 2014 | $2,589,000 | -27.9% | 160,032 | -27.5% | 0.00% | -20.0% |
Q1 2014 | $3,589,000 | +457.3% | 220,882 | +325.9% | 0.01% | +400.0% |
Q4 2013 | $644,000 | – | 51,864 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |